047920.KQ HLBPHARMA | KR7047920004
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 282.725.449.728 | 552.987.346.500 | 526.092.351.000 | 441.143.523.750 |
| Enterprise Value | 296.300.838.912 | 568.966.921.400 | 539.167.710.010 | 450.978.872.170 |
| Trailing P/E | - | 148,51 | 115,07 | 190,36 |
| Forward P/E | - | - | - | - |
| Price to Sales | 19,98 | 2,34 | 2,56 | 3,1 |
| Price to Book | - | 3,64 | 4,2 | 3,65 |
| EV/Revenue | 20,94 | 2,4 | 2,62 | 3,17 |
| EV/EBITDA | -47,55 | 61,57 | 17,24 | 16,24 |